Texas · 89th Legislature (2025) · Bill
HB 3318: Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 3318 is a bill introduced in the Texas House on February 25, 2025. According to its official title, it concerns: Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses. Primary sponsor: King, Suleman Lalani (Democratic). It lists 1 additional sponsor. Most recent recorded action (April 21, 2025): Left pending in committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| King | Primary sponsor | Not applicable (committee) | — | — |
| Suleman Lalani | Primary sponsor | Democratic | House | 76 |
| Mihaela Pleșa | Co-sponsor | Democratic | House | 70 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Left pending in committee
- Testimony taken/registration(s) recorded in committee
- Considered in public hearing
- Posting rule suspended
- Referred to Public Health
- Read first time
- Filed